Nano-biotechnology and its Innovative Perspective in Diabetes Management

Mini Rev Med Chem. 2022;22(1):89-114. doi: 10.2174/1389557521666210623164052.

Abstract

The occurrence of the diabetes happens due to the irregular operation of glucose in the body, which is also known as glucose homeostasis, thus leading to metabolic changes in the body. The two stages whether hypoglycemia or hyperglycemia differentiates diabetes into various categories and brought new innovative management for the new routes of administration of these disease condition. Various bio-nanotechnologies which are coupled with nano particulates, polymers, Liposome, various gold plated and Solid Lipids Particulates regulate the transcellular transport, non specific cellular uptake, and paracellular transport, which leads to oral, transdermal, Pulmonary, buccal, Nasal, specific gene oriented administration to avoid the non patience compliance with the parental routes of administration. Phytochemicals have an emerging strategy for the future prospects of diabetes management.

Keywords: Insulin.; Nano-biotechnology; diabetes; metabolic disease; nanoparticles; treatment.

MeSH terms

  • Diabetes Mellitus* / drug therapy
  • Glucose
  • Humans
  • Hypoglycemic Agents / therapeutic use
  • Insulin*

Substances

  • Hypoglycemic Agents
  • Insulin
  • Glucose